The Cigna Group (NYSE:CI) Shares Acquired by Cwm LLC

Cwm LLC boosted its position in The Cigna Group (NYSE:CI) by 0.4% during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 70,893 shares of the health services provider’s stock after acquiring an additional 298 shares during the quarter. Cwm LLC’s holdings in The Cigna Group were worth $24,560,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. Future Financial Wealth Managment LLC purchased a new position in The Cigna Group in the third quarter valued at about $191,000. Strategic Wealth Partners Ltd. increased its position in shares of The Cigna Group by 3.3% during the third quarter. Strategic Wealth Partners Ltd. now owns 1,398 shares of the health services provider’s stock worth $484,000 after acquiring an additional 45 shares during the last quarter. Brookstone Capital Management increased its holdings in The Cigna Group by 3.1% in the third quarter. Brookstone Capital Management now owns 1,338 shares of the health services provider’s stock valued at $464,000 after buying an additional 40 shares during the last quarter. City Holding Co. increased its holdings in The Cigna Group by 7.4% in the third quarter. City Holding Co. now owns 3,326 shares of the health services provider’s stock valued at $1,152,000 after buying an additional 229 shares during the last quarter. Finally, Atomi Financial Group Inc. increased its holdings in The Cigna Group by 9.7% in the third quarter. Atomi Financial Group Inc. now owns 1,590 shares of the health services provider’s stock valued at $551,000 after buying an additional 140 shares during the last quarter. Institutional investors and hedge funds own 86.99% of the company’s stock.

The Cigna Group Stock Up 1.1 %

Shares of NYSE:CI opened at $350.63 on Friday. The stock has a market cap of $99.60 billion, a price-to-earnings ratio of 28.79, a PEG ratio of 1.08 and a beta of 0.50. The company has a quick ratio of 0.71, a current ratio of 0.71 and a debt-to-equity ratio of 0.73. The Cigna Group has a 12-month low of $253.95 and a 12-month high of $370.83. The business’s 50 day moving average is $348.19 and its 200 day moving average is $344.86.

The Cigna Group (NYSE:CI) last released its quarterly earnings data on Thursday, August 1st. The health services provider reported $6.72 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $6.42 by $0.30. The Cigna Group had a return on equity of 17.83% and a net margin of 1.70%. The company had revenue of $60.52 billion for the quarter, compared to analyst estimates of $58.30 billion. During the same period in the previous year, the company posted $6.13 EPS. The firm’s revenue for the quarter was up 24.6% compared to the same quarter last year. On average, sell-side analysts forecast that The Cigna Group will post 28.48 earnings per share for the current fiscal year.

The Cigna Group Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Thursday, September 19th. Shareholders of record on Wednesday, September 4th were given a dividend of $1.40 per share. This represents a $5.60 dividend on an annualized basis and a yield of 1.60%. The ex-dividend date was Wednesday, September 4th. The Cigna Group’s payout ratio is 45.98%.

Analyst Ratings Changes

A number of equities analysts have commented on CI shares. Cantor Fitzgerald restated an “overweight” rating and issued a $400.00 target price on shares of The Cigna Group in a research note on Tuesday, October 1st. Stephens restated an “overweight” rating and issued a $410.00 target price on shares of The Cigna Group in a research report on Friday, August 2nd. Jefferies Financial Group upped their price target on The Cigna Group from $402.00 to $422.00 and gave the company a “buy” rating in a report on Tuesday, September 17th. Barclays upped their price target on The Cigna Group from $393.00 to $405.00 and gave the company an “overweight” rating in a report on Friday, August 2nd. Finally, JPMorgan Chase & Co. boosted their target price on shares of The Cigna Group from $435.00 to $438.00 and gave the company an “overweight” rating in a research note on Wednesday, August 21st. One equities research analyst has rated the stock with a hold rating, thirteen have given a buy rating and two have issued a strong buy rating to the stock. According to data from MarketBeat.com, the stock has an average rating of “Buy” and an average price target of $392.79.

Insider Transactions at The Cigna Group

In other The Cigna Group news, Director William J. Delaney III sold 2,691 shares of the stock in a transaction on Monday, August 19th. The stock was sold at an average price of $342.68, for a total transaction of $922,151.88. Following the sale, the director now directly owns 17,539 shares in the company, valued at approximately $6,010,264.52. This trade represents a 0.00 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Corporate insiders own 0.60% of the company’s stock.

About The Cigna Group

The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers.